title: Deal watch: Bristol-Myers Squibb acquires potential keys to treating rheumatoid arthritis.
authors.forename: Megan
authors.initials: M
authors.lastname: Cully
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004345:Drug Industry / Q000191:economics* / Q000458:organization & administration; D006801:Humans; D007373:Interinstitutional Relations
chemical_list: D018501:Antirheumatic Agents